CUMBERLAND PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cumberland Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.69M, a 9.22% increase year-over-year.
  • Cumberland Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$10.8M, a 90.5% decline year-over-year.
  • Cumberland Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$9.55M, a 67.5% decline from 2022.
  • Cumberland Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$5.7M, a 25.7% increase from 2021.
  • Cumberland Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$7.68M, a 20.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$10.8M -$1.69M +$172K +9.22% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$10.9M -$1.03M -$1.05M -4591% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$9.89M -$1.87M -$338K -22% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$9.55M -$6.18M -$3.9M -171% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$5.65M -$1.87M -$1.58M -547% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$4.08M $22.9K +$1.87M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$5.94M -$1.53M -$240K -18.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$5.7M -$2.28M +$2.08M +47.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$7.78M -$289K +$1.27M +81.5% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-13
Q2 2022 -$9.06M -$1.85M -$411K -28.6% Apr 1, 2022 Jun 30, 2022 10-K 2024-03-13
Q1 2022 -$8.65M -$1.29M -$968K -298% Jan 1, 2022 Mar 31, 2022 10-K 2024-03-13
Q4 2021 -$7.68M -$4.35M -$2.61M -149% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 -$5.07M -$1.56M -$355K -29.3% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-13
Q2 2021 -$4.71M -$1.44M +$145K +9.19% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-13
Q1 2021 -$4.86M -$324K +$1.52M +82.4% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-13
Q4 2020 -$6.38M -$1.75M +$1.65M +48.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$8.03M -$1.21M +$1.99M +62.2% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 -$10M -$1.58M -$208K -15.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 -$9.81M -$1.85M -$522K -39.4% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11
Q4 2019 -$9.29M -$3.39M -$101K -3.07% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 -$9.19M -$3.2M -$552K -20.9% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-12
Q2 2019 -$8.64M -$1.37M +$546K +28.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-12
Q1 2019 -$9.18M -$1.32M +$1.99M +60.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-12
Q4 2018 -$11.2M -$3.29M -$2.39M -265% Oct 1, 2018 Dec 31, 2018 8-K 2020-12-10
Q3 2018 -$8.78M -$2.64M -$1.81M -215% Jul 1, 2018 Sep 30, 2018 8-K 2020-12-10
Q2 2018 -$6.98M -$1.92M -$238K -14.2% Apr 1, 2018 Jun 30, 2018 8-K 2020-12-10
Q1 2018 -$6.74M -$3.32M -$2.66M -404% Jan 1, 2018 Mar 31, 2018 8-K 2020-12-10
Q4 2017 -$4.08M -$903K +$54K +5.65% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$4.14M -$839K -$969K -745% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-12
Q2 2017 -$3.17M -$1.68M -$1.58M -1496% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-12
Q1 2017 -$1.59M -$658K -$157K -31.4% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-12
Q4 2016 -$1.43M -$957K -$1.12M -689% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 -$313K $130K -$141K -52% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-09
Q2 2016 -$172K -$105K -$779K -116% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-09
Q1 2016 $607K -$501K -$505K -12262% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-09
Q4 2015 $1.11M $163K -$783K -82.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-13
Q3 2015 $1.9M $271K -$718K -72.6% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-13
Q2 2015 $2.61M $674K -$542K -44.6% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-13
Q1 2015 $3.15M $4.12K -$404K -99% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-13
Q4 2014 $3.56M $946K +$3.42M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 $141K $989K +$2.5M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$2.36M $1.22M +$2.36M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$4.72M $408K -$918K -69.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
Q4 2013 -$3.8M -$2.47M -$5.73M -176% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-09
Q3 2013 $1.92M -$1.51M -$4.49M -151% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-09
Q2 2013 $6.42M -$1.14M -$3.08M -159% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-09
Q1 2013 $9.5M $1.33M +$680K +105% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-09
Q4 2012 $8.82M $3.25M +$1.54M +90.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-11
Q3 2012 $7.28M $2.98M -$119K -3.85% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 $7.4M $1.94M -$1.69M -46.6% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-11
Q1 2012 $9.09M $646K -$762K -54.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
Q4 2011 $9.85M $1.71M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-12
Q3 2011 $3.1M +$655K +26.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-12
Q2 2011 $3.63M +$2.62M +260% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-12
Q1 2011 $1.41M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-12
Q3 2010 $2.44M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 $1.01M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.